White Paper

Effective EDC Should Be Accessible And Affordable For All Clinical Trials

Source: IBM Clinical Development
Effective EDC Should Be Accessible And Affordable For All Clinical Trials

The number of clinical trials conducted per year, their complexity, and the percentage of trials experiencing delays have all been increasing in recent years, accompanied by spiraling costs and lengthening trial times. This trend, along with a rise in overall drug development costs, has been occurring at a time when governments, payers, and patients are demanding that pharmaceutical manufacturers provide evidence of measurable value for any new treatment.

All research efforts deserve to benefit from advanced IT solutions. Modular, cloud-based electronic data capture platforms enable efficient management of clinical trials regardless of study size and complexity. These effective EDC platforms should be made affordable for all clinical trials so that the real end goal – getting new, effective medicines to the patients who need them – can be achieved as efficiently as possible.